Antibodies to Epstein-Barr-virus antigens before and after the development of Burkitt's lymphoma in a patient treated for Hodgkin's disease.
D000914:Antibodies, Viral / Q000032:analysis*; D000956:Antigens, Viral; D002051:Burkitt Lymphoma / Q000276:immunology* / Q000473:pathology; D002648:Child; D004854:Herpesvirus 4, Human / Q000276:immunology*; D006689:Hodgkin Disease / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D008297:Male; D008466:Mechlorethamine / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000914:Antibodies, Viral; D000956:Antigens, Viral; D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D011241:Prednisone